Table 1.
Recommendations | |
---|---|
Recruitment and sample selection | Develop consensus inclusion and exclusion criteria for the novel phenotype |
Determine the gait measures required to define criteria | |
Identify community-based and clinical recruitment centers (eg, ADRCs) | |
Recruit from diverse and understudied populations | |
Intervention design | Consider adaptive and individually tailored interventions |
Focus on multimodal interventions that can target multiple pathways simultaneously | |
Strive for enjoyable and challenging interventions to increase adherence and maintenance | |
Consider variable impact by subgroups (eg, sex, age, disability) | |
Carefully select control participants | |
Include cross-disciplinary teams in intervention development | |
Methods to measure effectiveness | Focus on multiple and dependent pathways |
Incorporate qualitative and quantitative markers of brain health | |
Develop a detailed baseline phenotype of study participants including multiple cognitive and mobility measures | |
Consider noninvasive, wearable technology to assess outcomes continuously in daily life |
Note: ADRC = Alzheimer’s Disease Research Center; CNS = central nervous system.